Vyne Therapeutics Inc (NASDAQ:VYNE)
| 3.37 Delayed Data As of Dec 01 |  +0.06 / +1.81%Today’s Change | 1.99 Today|||52-Week Range 8.73 | +24.81% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 4.0K | 12.0K | 191.0K | 166.0K | ||
| Operating Expenses | Gross Income | -4.0K | -12.0K | -191.0K | -166.0K | |
| General Expenses | 13.7M | 18.4M | 19.5M | 17.1M | ||
| Research And Development | 10.7M | 15.1M | 15.9M | 13.5M | ||
| Total Operating Expenses | 13.7M | 18.4M | 19.7M | 17.2M | ||
| Non-Operating Expenses | Operating Income | -13.7M | -18.4M | -19.7M | -17.2M | |
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -12.8M | -17.6M | -18.9M | -16.5M | |
| Net Income | -12.8M | -17.6M | -18.9M | -16.5M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 23.0M | 23.2M | 23.3M | 23.9M | |
| Shares To Calculate EPS Diluted | 23.0M | 23.2M | 23.3M | 23.9M | ||
| Earnings Per Share | EPS | -$0.56 | -$0.76 | -$0.81 | -$0.69 | |
| EPS Diluted | -$0.56 | -$0.76 | -$0.81 | -$0.69 | ||
